715 related articles for article (PubMed ID: 10770662)
21. Cyclosporine in steroid dependent and resistant childhood nephrotic syndrome.
Iyengar A; Karthik S; Kumar A; Biswas S; Phadke K
Indian Pediatr; 2006 Jan; 43(1):14-9. PubMed ID: 16465001
[TBL] [Abstract][Full Text] [Related]
22. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
Sancewicz-Pach K; Słowiaczek E; Kwinta-Rybicka J; Wilkosz K; Drozdz D; Nowak J
Przegl Lek; 1996; 53(4):365-8. PubMed ID: 8711193
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial.
Choudhry S; Bagga A; Hari P; Sharma S; Kalaivani M; Dinda A
Am J Kidney Dis; 2009 May; 53(5):760-9. PubMed ID: 19268410
[TBL] [Abstract][Full Text] [Related]
24. [Cyclosporin A treatment of 83 children with nephrotic syndrome of different pathological types].
Xia ZK; Liu GL; Gao YF; Fu J; Fu YF; Zhang LF; Fan ZM
Zhonghua Er Ke Za Zhi; 2003 Nov; 41(11):813-6. PubMed ID: 14728885
[TBL] [Abstract][Full Text] [Related]
25. Henoch-Schönlein purpura nephritis with nephrotic-range proteinuria: histological regression possibly associated with cyclosporin A and steroid treatment.
Shin JI; Park JM; Shin YH; Kim JH; Lee JS; Jeong HJ
Scand J Rheumatol; 2005; 34(5):392-5. PubMed ID: 16234188
[TBL] [Abstract][Full Text] [Related]
26. Long-term results of cyclosporine-induced remission of relapsing nephrotic syndrome in children.
Kim PK; Kim KS; Pai KS; Kim JH; Choi IJ
Yonsei Med J; 1997 Oct; 38(5):307-18. PubMed ID: 9409194
[TBL] [Abstract][Full Text] [Related]
27. Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children.
Gulati S; Prasad N; Sharma RK; Kumar A; Gupta A; Baburaj VP
Nephrol Dial Transplant; 2008 Mar; 23(3):910-3. PubMed ID: 18039644
[TBL] [Abstract][Full Text] [Related]
28. Treatment course of steroid-dependent nephrotic syndrome: emphasized on treatment effect.
Chen SY; Wu CY; Tsai IJ; Tsau YK
Nephrology (Carlton); 2010 Apr; 15(3):336-9. PubMed ID: 20470303
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporin in steroid-resistant nephrotic syndrome.
Adhikari M; Coovadia HM
S Afr Med J; 1994 Nov; 84(11):753-6. PubMed ID: 7495012
[TBL] [Abstract][Full Text] [Related]
30. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
Sabry A; El-Husseini A; El-Dahshan K; Sobh M
Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
[TBL] [Abstract][Full Text] [Related]
31. Follow-up study of children with nephrotic syndrome treated with a long-term moderate dose of cyclosporine.
Hino S; Takemura T; Okada M; Murakami K; Yagi K; Fukushima K; Yoshioka K
Am J Kidney Dis; 1998 Jun; 31(6):932-9. PubMed ID: 9631836
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporine utilization in idiopathic nephrotic syndrome in children.
Saeed B; Ossman MI; Sheriff S
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):497-502. PubMed ID: 17186683
[TBL] [Abstract][Full Text] [Related]
33. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome.
Kyrieleis HA; Levtchenko EN; Wetzels JF
Am J Kidney Dis; 2007 May; 49(5):592-7. PubMed ID: 17472840
[TBL] [Abstract][Full Text] [Related]
34. Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome.
Ishikura K; Yoshikawa N; Hattori S; Sasaki S; Iijima K; Nakanishi K; Matsuyama T; Yata N; Ando T; Honda M;
Nephrol Dial Transplant; 2010 Dec; 25(12):3956-62. PubMed ID: 20530497
[TBL] [Abstract][Full Text] [Related]
35. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
36. Effect of levamisole in steroid-dependent nephrotic syndrome.
Madani A; Isfahani ST; Rahimzadeh N; Fereshtehnejad SM; Hoseini R; Moghtaderi M; Mohseni P; Ataiee N
Iran J Kidney Dis; 2010 Oct; 4(4):292-6. PubMed ID: 20852369
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
du Buf-Vereijken PW; Wetzels JF
Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
[TBL] [Abstract][Full Text] [Related]
38. [Multicenter survey of diagnostic and therapeutic status in Chinese childhood patients with steroid-sensitive, relaping/steroid-dependent nephrotic syndrome].
Working Group For National Survey On Status Of Diagnosis And Treatment Of Childhood Renal Diseases
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):194-200. PubMed ID: 24824389
[TBL] [Abstract][Full Text] [Related]
39. Levamisole vs. cyclophosphamide for frequently-relapsing steroid-dependent nephrotic syndrome.
Alsaran K; Grisaru S; Stephens D; Arbus G
Clin Nephrol; 2001 Oct; 56(4):289-94. PubMed ID: 11680658
[TBL] [Abstract][Full Text] [Related]
40. Methylprednisolone treatment in children with nephrotic primary focal segmental glomerulosclerosis.
Opastirakul S; Chartapisak W
J Med Assoc Thai; 2006 Dec; 89(12):2145-9. PubMed ID: 17214070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
